Literature DB >> 18489495

Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).

Roberta Ara1, John Brazier.   

Abstract

OBJECTIVE: The objective of the study was to derive a method to predict a mean cohort EQ-5D preference-based index score using published mean statistics of the eight dimension scores describing the SF-36 health profile.
METHODS: Ordinary least square regressions models are derived using patient level data (n = 6350) collected during 12 clinical studies. The models were compared for goodness of fit using standard techniques such as variance explained, the magnitude of errors in predicted values, and the proportion of values within the minimal important difference of the EQ-5D. Predictive abilities were also compared using summary statistics from both within-sample subgroups and published studies.
RESULTS: The models obtained explained more than 56% of the variance in the EQ-5D scores. The mean predicted EQ-5D score was correct to within two decimal places for all models and the absolute error for the individual predicted values was approximately 0.13. Using summary statistics to predict within-sample subgroup mean EQ-5D scores, the mean errors (mean absolute errors) ranged from 0.021 to 0.077 (0.045-0.083). These statistics for the out-of-sample published data sets ranged from 0.048 to 0.099 (0.064-0.010).
CONCLUSIONS: The models provided researchers with a mechanism to estimate EQ-5D utility data from published mean dimension scores. This research is unique in that it uses mean statistics from published studies to validate the results. While further research is required to validate the results in additional health conditions, the algorithms can be used to derive additional preference-based measures for use in economic analyses.

Entities:  

Mesh:

Year:  2008        PMID: 18489495     DOI: 10.1111/j.1524-4733.2008.00352.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  65 in total

1.  Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.

Authors:  Mark Parker; Alan Haycox; Jane Graves
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

2.  The cost of somatisation among the working-age population in England for the year 2008-2009.

Authors:  Sarah L Bermingham; Alan Cohen; John Hague; Michael Parsonage
Journal:  Ment Health Fam Med       Date:  2010-06

3.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

4.  Cost utility of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  Amanda Johner; Adam Raymakers; Sam M Wiseman
Journal:  Surg Endosc       Date:  2012-07-07       Impact factor: 4.584

5.  Quality of life, health status, and health service utilization related to a new measure of health literacy: FLIGHT/VIDAS.

Authors:  Raymond L Ownby; Amarilis Acevedo; Robin J Jacobs; Joshua Caballero; Drenna Waldrop-Valverde
Journal:  Patient Educ Couns       Date:  2014-05-14

6.  Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.

Authors:  Vibeke Strand; Martin Bergman; Jasvinder A Singh; Allan Gibofsky; Alan Kivitz; Clarence Young
Journal:  Clin Rheumatol       Date:  2017-02-13       Impact factor: 2.980

Review 7.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.

Authors:  Sutat Kantito; Surasak Saokaew; Sukit Yamwong; Prin Vathesatogkit; Wisuit Katekao; Piyamitr Sritara; Nathorn Chaiyakunapruk
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

9.  Reverse-total shoulder arthroplasty cost-effectiveness: A quality-adjusted life years comparison with total hip arthroplasty.

Authors:  Daniel Bachman; John Nyland; Ryan Krupp
Journal:  World J Orthop       Date:  2016-02-18

10.  Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36.

Authors:  Janel Hanmer
Journal:  Value Health       Date:  2009-03-24       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.